Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleArticle

THE EFFECT OF PHENOBARBITAL ON DRUG METABOLIC ENZYME ACTIVITY, ULTRASTRUCTURE AND GROWTH OF A "MINIMAL DEVIATION" HEPATOMA (MORRIS 7800)

Larry A. Rogers, H. P. Morris and James R. Fouts
Journal of Pharmacology and Experimental Therapeutics July 1967, 157 (1) 227-244;
Larry A. Rogers
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H. P. Morris
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James R. Fouts
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

The drug metabolic enzyme pattern and the ultrastructure of a "minimal deviation" hepatoma (Morris 7800) were studied before and after phenobarbital treatment of animals bearing these tumors. The control hepatoma cytoplasm contained an extensively developed endoplasmic reticulum. However, the prominent, parallel stacks of flattened, rough-surfaced endoplasmic reticulum cisternae, characteristic of liver parenchymal cells, were absent in the hepatoma. The smooth-surfaced endoplasmic reticulum was relatively abundant in the hepatoma and was even more easily visualized than in normal liver because of the absence of large numbers of densely staining glycogen granules. The Morris 7800 hepatoma microsomal enzymes metabolized a wide variety of chemical substrates even before phenobarbital treatment of animals bearing these tumors. Kinetic studies demonstrated similar apparent Michaelis constants (Km) and estimated maximal enzyme reaction velocities (Vmax) for benzpyrene and aniline hydroxylation in the hepatoma and rat liver. The apparent Km value for the side chain oxidation of hexobarbital was the same for the hepatoma and rat liver. However, the estimated Vmax for the metabolism of hexobarbital was greatly reduced in the hepatoma as compared with liver. Acute phenobarbital administration caused some perinuclear increase in small tubular, smooth-surfaced endoplasmic reticulum (SER) in the hepatoma, and an extensive increase in the perinuclear small tubular type of SERl in the live-parenchymal cells. This phenobarbital-induced increase in SER membranes was accompanied by an increase in the ability of both liver and tumor to metabolize hexobarbital. Chronic phenobarbital administration caused extensive proliferation of the SER and increases in the rate of side chain oxidation of hexobarbitai in both liver and hepatoma. The form of the SER of the liver or hepatoma after long-term phenobarbital administration was an irregularly dilated type of type in contrast to the small tubules seen after acute exposures to phenobarbital. Rats bearing Morris 7800 hepatoma had normal levels of the microsomal drug-metabolizing enzymes in their liver. The presence of nonnecrotic tumor tissue, therefore, did not appear to affect drug metabolism in the host liver. Host-liver drug metabolic enzyme activity was affected just before the animal was killed by the tumor, but this was believed to be a nonspecific effect which can be mimicked by any near fatal disease state or by severe starvation.

Footnotes

    • Received September 21, 1966.
    • Accepted February 1, 1967.
  • © 1967 by The Williams & Wilkins Company

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 157, Issue 1
1 Jul 1967
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
THE EFFECT OF PHENOBARBITAL ON DRUG METABOLIC ENZYME ACTIVITY, ULTRASTRUCTURE AND GROWTH OF A "MINIMAL DEVIATION" HEPATOMA (MORRIS 7800)
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

THE EFFECT OF PHENOBARBITAL ON DRUG METABOLIC ENZYME ACTIVITY, ULTRASTRUCTURE AND GROWTH OF A "MINIMAL DEVIATION" HEPATOMA (MORRIS 7800)

Larry A. Rogers, H. P. Morris and James R. Fouts
Journal of Pharmacology and Experimental Therapeutics July 1, 1967, 157 (1) 227-244;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

THE EFFECT OF PHENOBARBITAL ON DRUG METABOLIC ENZYME ACTIVITY, ULTRASTRUCTURE AND GROWTH OF A "MINIMAL DEVIATION" HEPATOMA (MORRIS 7800)

Larry A. Rogers, H. P. Morris and James R. Fouts
Journal of Pharmacology and Experimental Therapeutics July 1, 1967, 157 (1) 227-244;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • PST3093 Stimulates SERCA2a and Improves Cardiac Function
  • CRV431 Decreases Liver Fibrosis and Tumor Development
  • Is Hydroxylamine-Induced Cytotoxicity a Valid Marker for Hypersensitivity Reactions to Sulfamethoxazole in Human Immunodeficiency Virus-Infected Individuals?
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics